Disclosure LibraryPractitioner guidance for every reporting disclosure

Search the Disclosure Library

Find a datapoint, metric or topic across companies' published reports — and jump to the exact page.

or open the Disclosure Card for a requirement
18 reports · Code match · “GRI 2-25”
H.Essers
Ground Transportation — Trucking · Belgium
2024
25 GRI 305-4 GHG Emissions intensity 26 GRI 306-3 Waste generated 27 GRI 306-4 Waste directed from disposal 28 GRI 306-5 Waste directed from disposal 29 GRI 2
✓ Assured · Vinçotte
Jump to p.66 →
Zydus Lifesciences Limited
Pharmaceuticals / Biotech / Life Sciences · India
2025
25 Policy Influence Contributions and other Spending 35 Principle 7(E.1), (L.1) 17.16, 17.17, 17.19 1.6.1 26 Largest contribu­ tions/Spending 35 Principle 7(E.1), (L.1) 17.16, 17.17, 17.19 1.6.2 27 Lobbying and …
Assurance not stated
SK Telecom Co., Ltd.
Telecommunication Services · South Korea
2024
GRI 2: General Disclosures 2021 2-16 Communication on Material Issues 28-29, 56-62 2-17 Comprehensive Knowledge of the Highest Governance Body 25
✓ Assured · EY
Jump to p.194 →
Tanla Platforms Limited
Software and Services · India
2025
25. Complaints/Grievances on any of the nine principles under the National Guidelines on Responsible Business Conduct:[2-25] Stakeholder group from whom complaint is received Grievance redressal mecha- nism in …
✓ Assured · Deloitte
Enel Américas S.A.
Electric Utilities / IPP / Energy Traders · Chile
2024
25 GRI 304: Biodiversity (2016) 304-1 Operational sites owned, leased, managed or adjacent to protected areas and areas of high biodiversity value outside protected areas 29, 30 GRI 304: Biodiversity (2016) …
✓ Assured · EY
Jump to p.105 →
ÖBB Holding / Rail Cargo Group
Ground Transportation — Railroads · Austria
2024
GRI Social affairs (social and employee matters and respect for human rights in accordance with NaDiVeG) ESRS S1 – Own workforce SBM-2 Interests and views of stakeholders Material E.3. p. 116 10, 11, 12, 13, 14, 15, …
✓ Assured · Ernst & Young
Jump to p.230 →
Celltrion, Inc.
Pharmaceuticals / Biotech / Life Sciences · South Korea
2025
25 2-15 Conflicts of interest 110-111 2-16 Communication of critical concerns 110 FY2024 Annual Report 369- 372p 2-17 Collective knowledge of the highest governance body 77, 110 2-18 Evaluation of …
Assurance not stated
Jump to p.77 →

Results are passages from companies' own published reports. Links open the issuer's original PDF at the cited page.